Skip to Content

Bupivacaine with epinephrine Injection

Last Updated: February 12, 2018
Status: Resolved

Bupivacaine with epinephrine Injection

Products Affected - Description
  • Bupivacaine (with epinephrine 1:200,000) injection, Pfizer

0.25%, 10 mL vial, 50 count (NDC 00409-9042-01)
0.25%, 30 mL vial, 100 count (NDC 00409-9042-17)
0.25%, 50 mL vial, 25 count (NDC 00409-9043-01)
0.5%, 10 mL vial, 50 count (NDC 00409-9045-01)
0.5%, 30 mL vial, 100 count (NDC 00409-9045-17)
0.5%, 50 mL vial, 25 count (NDC 00409-9046-01)
 
Marcaine (with epinephrine 1:200,000) injection, Pfizer
0.25%, 10 mL vial, 10 count (NDC 00409-1746-10)
0.25%, 30 mL vial, 10 count (NDC 00409-1746-30)
0.25%, 50 mL vial, 1 count (NDC 00409-1752-50)
0.5%, 10 mL vial, 10 count (NDC 00409-1749-10)
0.5%, 30 mL vial, 10 count (NDC 00409-1749-29)
0.5%, 50 mL vial, 1 count (NDC 00409-1755-50)
 
Sensorcaine (with epinephrine 1:200,000) injection, Fresenius Kabi
0.25%, 50 mL vial, 25 count (NDC 63323-0461-57)
0.5%, 50 mL vial, 25 count (NDC 63323-0463-57)
 
Sensorcaine-MPF (with epinephrine 1:200,000) injection, Fresenius Kabi
0.25%, 10 mL vial, 25 count (NDC 63323-0468-17)
0.25%, 30 mL vial, 25 count (NDC 63323-0468-37)
0.5%, 10 mL vial, 25 count (NDC 63323-0462-17)
0.5%, 30 mL sterile pack vial, 5 count (NDC 63323-0462-31)
0.5%, 30 mL vial, 25 count (NDC 63323-0462-37)
0.75%, 30 mL vial, 25 count (NDC 63323-0460-37)
Reason for the Shortage
    • Fresenius Kabi has bupivacaine and epinephrine on shortage due to increased demand and manufacturing delays.
    • Pfizer has bupivacaine with epinephrine on shortage due to manufacturing delays.
Available Products
  • There is insufficient supply for usual ordering

Estimated Resupply Dates

    • Fresenius Kabi has 0.25% Sensorcaine-MPF with epinephrine 30 mL vials on intermittent back order and the company is releasing product as it becomes available. The 0.25% Sensorcaine-MPF with epinephrine 10 mL vials are on back order and the company estimates a release date of mid-February 2018. The 0.25% Sensorcaine with epinephrine 50 mL vials are on back order and the company estimates a release date of mid-February 2018. The 0.5% Sensorcaine-MPF with epinephrine 30 mL vials are on intermittent back order and the company is releasing product as it becomes available. The 0.5% Sensorcaine-MPF with epinephrine 10 mL vials are on back order and the company estimates a release date of mid- to late-February 2018. The 0.5% Sensorcaine-MPF with epinephrine 30 mL sterile packs are on back order and the company cannot estimate a release date. The 0.5% Sensorcaine with epinephrine 50 mL vials are on back order and the company estimates a release date of mid- to late-March 2018. The 0.75% Sensorcaine with epinephrine 30 mL vials are on back order and the company cannot estimate a release date.
    • Pfizer has 0.25% bupivacaine with epinephrine 10 mL and 30 mL preservative-free vials on back order and the company estimates a release date of June 2018 for the 10 mL vials and mid-February 2018 for the 30 mL vials. The 0.25% bupivacaine with epinephrine 50 mL vials are on back order and the company estimates a release date of June 2018. The 0.5% bupivacaine with epinephrine 10 mL preservative-free vials are on back order and the company estimates a release date of late-February 2018. The 0.5% bupivacaine with epinephrine 30 mL preservative-free vials are on back order and the company estimates a release date of late-February 2018. The 0.5% bupivacaine with epinephrine 50 mL vials are on back order and the company estimates a release date of June 2018.
    • Pfizer has 0.25% Marcaine with epinephrine 10 mL and 30 mL preservative-free vials on back order and the company estimates a release date of March 2019. The 0.25% Marcaine with epinephrine 50 mL vials are on back order and the company estimates a release date of March 2019. The 0.5% Marcaine with epinephrine 10 mL and 30 mL preservative-free vials are on back order and the company estimates a release date of March 2019. The 0.5% Marcaine with epinephrine 50 mL vials are on back order and the company estimates a release date of March 2019.

Updated

February 12 and 5, January 22 and 10, 2018; December 19, November 22 and 10, September 30 and 8, August 18, July 31, 21 and 6, June 21, 9 and 6, May 19, 11 and 2, April 27 and 7, March 21, 12 and 1, February 21, 16 and 7, January 26 and 13, 2017; December 19 and 2, November 21, 11 and 7, October 19, September 27, 13 and 2, 2016, University of Utah, Drug Information Service. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide